Overview
Kishor Singapuri is a Radiation Oncologist in Lancaster, Pennsylvania. Dr. Singapuri is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Angiosarcoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
Locations
2100 Harrisburg Pike, Lancaster, PA 17601
40 V Twin Dr, Suite 102, Gettysburg, PA 17325
Abramson Cancer Center Penn Presbyterian
Keith Cengel is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Cengel is rated as an Elite provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Mesothelioma, Lung Cancer, Metastatic Pleural Tumor, Small Cell Lung Cancer (SCLC), and Liver Embolization. Dr. Cengel is currently accepting new patients.
Penn Radiation Oncology Valley Forge
Et-tsu Chen is a Radiation Oncologist in Berwyn, Pennsylvania. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Mesothelioma. Her top areas of expertise are Anal Cancer, Intraductal Papilloma, Primary Lymphoma of the Brain, and Familial Prostate Cancer. Dr. Chen is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Russell Hales, M.D., is an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also is director of the thoracic multidisciplinary clinic. His research focuses on reconstructing health delivery models to enhance value and improve clinical outcomes. He also studies the effect of immunotherapy and RT in thoracic tumors. Dr. Hales was awarded an R21 grant to study the use of dynamic MRI in predicting tumor motion in patient with lung cancer. Taken together, his research focuses on optimizing patient outcomes using resources from physics, engineering, biology and health delivery systems. Dr. Hales’ efforts extend beyond radiation oncology and clinical management. He has helped to lead in the thoracic oncology program, which includes 20 faculty members and nearly 50 staff, to help chart a vision for this program’s future. In the last four years, the program has gradually transitioned from The Johns Hopkins Hospital campus to Johns Hopkins Bayview Medical Center. Dr. Hales was tasked to head the building and design committee that worked with architects to create a structure conducive to 21st century oncology care. His work extends beyond the bricks and mortar of the new cancer center today to team development within the thoracic oncology program. Simply put, the thoracic oncology move was designed to conceptualize the transition of care from department-based to disease-based medicine. As such, Dr. Hales has worked to integrate the efforts of specialists in medical oncology, thoracic surgery, interventional pulmonology, pathology and radiology. These experts share a clinical space focused on thoracic malignancies and bring a patient-centered model of care to their group. Dr. Hales graduated from Brigham Young University Summa Cum Laude and Valedictorian in 2001. He attended Johns Hopkins Medicine and graduated with an M.D. in 2005. He trained on the Osler Medical Service and attended residency at Johns Hopkins. He joined the faculty at Hopkins in 2010. Dr. Hales focus in program building, research and clinical endeavors is robust, but he understands the key role of academia in training future leaders in medicine. He has been awarded Teacher of the Year in the department of radiation oncology at Hopkins for three of the last six years. He is a well-respected lecturer and travels nationally to speak at conferences and educational workshops about novel therapies in lung and esophagus cancer. Make A Gift. Dr. Hales is rated as a Distinguished provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Thymic Epithelial Tumor, Non-Small Cell Lung Cancer (NSCLC), and Endoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AngiosarcomaDr. Singapuri isAdvanced. Learn about Angiosarcoma.
- Familial Prostate CancerDr. Singapuri isAdvanced. Learn about Familial Prostate Cancer.
- Lung CancerDr. Singapuri isAdvanced. Learn about Lung Cancer.
- Muscle Invasive Bladder CancerDr. Singapuri isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Pleuropulmonary BlastomaDr. Singapuri isAdvanced. Learn about Pleuropulmonary Blastoma.
- Prostate CancerDr. Singapuri isAdvanced. Learn about Prostate Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Singapuri isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Adult Soft Tissue SarcomaDr. Singapuri isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Singapuri isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Singapuri isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Singapuri isExperienced. Learn about Anal Cancer.
- AstrocytomaDr. Singapuri isExperienced. Learn about Astrocytoma.
